{"id":"seasonal-trivalent-vaccine","safety":{"commonSideEffects":[{"rate":"10–30","effect":"Injection site soreness or erythema"},{"rate":"5–15","effect":"Myalgia"},{"rate":"5–10","effect":"Headache"},{"rate":"1–5","effect":"Low-grade fever"},{"rate":"5–10","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated or attenuated influenza virus antigens representing three circulating strains (typically two A subtypes and one B lineage). Upon administration, it triggers both humoral and cellular immune responses, leading to the production of strain-specific antibodies and memory B cells that recognize and neutralize the vaccine strains if encountered naturally.","oneSentence":"The seasonal trivalent influenza vaccine stimulates the immune system to produce antibodies against three strains of influenza virus, providing protection against seasonal flu infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:03.532Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT07291635","phase":"PHASE1, PHASE2","title":"Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine","status":"RECRUITING","sponsor":"Aramis Biotechnologies Inc.","startDate":"2026-02-25","conditions":"Influenza","enrollment":728},{"nctId":"NCT03650114","phase":"PHASE3","title":"Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2018-12-28","conditions":"Relapsing Multiple Sclerosis","enrollment":1882},{"nctId":"NCT00782431","phase":"PHASE3","title":"Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2008-11","conditions":"Influenza","enrollment":3208},{"nctId":"NCT00800605","phase":"PHASE3","title":"Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2008-12","conditions":"Influenza","enrollment":7250},{"nctId":"NCT06664151","phase":"EARLY_PHASE1","title":"A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcinoma (CSCC) Patients Awaiting Curative Excision","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-11-26","conditions":"Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer","enrollment":25},{"nctId":"NCT01773928","phase":"PHASE3","title":"Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2013-01","conditions":"Influenza","enrollment":1928},{"nctId":"NCT06602024","phase":"PHASE3","title":"A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2024-09-16","conditions":"Seasonal Influenza","enrollment":40817},{"nctId":"NCT05663463","phase":"NA","title":"Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2023-09-11","conditions":"Solid Organ Transplant","enrollment":74},{"nctId":"NCT03312699","phase":"PHASE1","title":"Effects of Aging on Primary and Secondary Vaccine Responses","status":"COMPLETED","sponsor":"Stanford University","startDate":"2017-09-19","conditions":"Influenza, Hepatitis A, Typhoid","enrollment":54},{"nctId":"NCT03777163","phase":"PHASE4","title":"Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2019-04-22","conditions":"Influenza","enrollment":632},{"nctId":"NCT02385123","phase":"PHASE4","title":"Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-04-01","conditions":"Influenza, Influenza Immunisation","enrollment":60},{"nctId":"NCT00566345","phase":"PHASE3","title":"Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2007-11","conditions":"Influenza","enrollment":3670},{"nctId":"NCT04695717","phase":"PHASE3","title":"This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam","status":"COMPLETED","sponsor":"Vietnam Military Medical University","startDate":"2020-09-05","conditions":"Influenza","enrollment":864},{"nctId":"NCT04484532","phase":"EARLY_PHASE1","title":"Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2017-10-17","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":130},{"nctId":"NCT01344057","phase":"PHASE2","title":"Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2011-05","conditions":"Seasonal Influenza","enrollment":63},{"nctId":"NCT02523287","phase":"PHASE4","title":"Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-10-02","conditions":"Safety Markers of Adjuvanted Influenza Vaccine","enrollment":240},{"nctId":"NCT03658629","phase":"PHASE2","title":"Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults","status":"TERMINATED","sponsor":"Novavax","startDate":"2018-09-24","conditions":"Influenza, Human","enrollment":1375},{"nctId":"NCT03438487","phase":"","title":"Flucelvax (TIVc or QIVc) Pregnancy Registry","status":"COMPLETED","sponsor":"Seqirus","startDate":"2017-09-01","conditions":"Influenza, Human, Pregnancy, Birth Defect","enrollment":692},{"nctId":"NCT01676402","phase":"PHASE1","title":"Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-08","conditions":"Influenza","enrollment":316},{"nctId":"NCT04548518","phase":"PHASE3","title":"Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Elderly","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2020-08-03","conditions":"Influenza","enrollment":816},{"nctId":"NCT00987350","phase":"PHASE4","title":"Safety Study of Seasonal Influenza Vaccine by Jet Injection","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2010-01","conditions":"Healthy Adults","enrollment":60},{"nctId":"NCT01863849","phase":"PHASE4","title":"Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2013-08-22","conditions":"Influenza Prophylaxis","enrollment":120},{"nctId":"NCT02387294","phase":"PHASE3","title":"Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents","status":"COMPLETED","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","startDate":"2014-10","conditions":"Human Influenza","enrollment":120},{"nctId":"NCT01157702","phase":"PHASE3","title":"Yearly Strain Variation Study, 2010/2011","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2010-07","conditions":"Influenza, Seasonal Influenza","enrollment":110},{"nctId":"NCT01422200","phase":"PHASE4","title":"Flu Vaccine Study in Neuromuscular Patients 2011","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2011-08","conditions":"Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Congenital Muscular Dystrophy","enrollment":22},{"nctId":"NCT04515368","phase":"NA","title":"A Pilot Clinical Study of PET Scanning in Evaluation of Vaccine Reactogenicity","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2016-06-10","conditions":"Positron-Emission Tomography, Immunization Reaction","enrollment":54},{"nctId":"NCT03390166","phase":"PHASE2, PHASE3","title":"Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2017-07-24","conditions":"Influenza","enrollment":945},{"nctId":"NCT02894840","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2015-11","conditions":"Influenza","enrollment":340},{"nctId":"NCT01561989","phase":"NA","title":"Cholecalciferol and Flu Vaccine in Treating Healthy Participants","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2011-10","conditions":"Healthy, no Evidence of Disease","enrollment":11},{"nctId":"NCT03095599","phase":"PHASE2, PHASE3","title":"Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3","status":"COMPLETED","sponsor":"Institute of Vaccines and Medical Biologicals, Vietnam","startDate":"2017-03-20","conditions":"Influenza, Human","enrollment":889},{"nctId":"NCT02438423","phase":"PHASE1","title":"Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle","status":"COMPLETED","sponsor":"Mark Prausnitz","startDate":"2015-06","conditions":"Influenza","enrollment":100},{"nctId":"NCT02935192","phase":"PHASE3","title":"Phase 3 Trial of Serbian Seasonal Influenza Vaccine","status":"COMPLETED","sponsor":"Institute of Virology, Vaccines and Sera, Torlak","startDate":"2016-11-28","conditions":"Influenza","enrollment":480},{"nctId":"NCT02598089","phase":"PHASE1","title":"Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S)","status":"COMPLETED","sponsor":"Institute of Vaccines and Medical Biologicals, Vietnam","startDate":"2015-11","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT03392207","phase":"","title":"Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2018-04-23","conditions":"Influenza, Human, Orthomyxoviridae Infections, RNA Virus Infections","enrollment":403},{"nctId":"NCT02585700","phase":"PHASE1","title":"A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine","status":"COMPLETED","sponsor":"Institute of Virology, Vaccines and Sera, Torlak","startDate":"2015-11","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT03784885","phase":"PHASE2","title":"A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult","status":"COMPLETED","sponsor":"Advagene Biopharma Co. Ltd.","startDate":"2017-09-01","conditions":"Influenza Infection","enrollment":345},{"nctId":"NCT01609998","phase":"PHASE1","title":"Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-06","conditions":"Influenza","enrollment":75},{"nctId":"NCT01051349","phase":"PHASE2","title":"Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis","status":"COMPLETED","sponsor":"Biogen","startDate":"2010-03-31","conditions":"Relapsing-Remitting Multiple Sclerosis","enrollment":410},{"nctId":"NCT01924169","phase":"PHASE2","title":"Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-11-24","conditions":"Hematologic Disorder","enrollment":3},{"nctId":"NCT01811823","phase":"PHASE4","title":"Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2014-03-31","conditions":"Influenza, HIV, Tuberculosis","enrollment":301},{"nctId":"NCT00968890","phase":"PHASE2","title":"Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-09-12","conditions":"Influenza","enrollment":168},{"nctId":"NCT00985673","phase":"PHASE2","title":"Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-10-01","conditions":"Influenza","enrollment":611},{"nctId":"NCT02133781","phase":"PHASE4","title":"B-cell Immunity to Influenza (SLVP017)- Year 1, 2009","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-07","conditions":"Influenza","enrollment":51},{"nctId":"NCT03020537","phase":"PHASE4","title":"B-cell Immunity to Influenza (SLVP017)- Year 5, 2013","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-10","conditions":"Influenza","enrollment":8},{"nctId":"NCT02141581","phase":"PHASE4","title":"Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-08","conditions":"Influenza","enrollment":86},{"nctId":"NCT01202552","phase":"NA","title":"Two-site Intradermal Influenza Vaccination in Elderly","status":"COMPLETED","sponsor":"Queen Saovabha Memorial Institute","startDate":"2010-10","conditions":"Influenza","enrollment":180},{"nctId":"NCT02988739","phase":"PHASE1","title":"Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine","status":"COMPLETED","sponsor":"Pantec Biosolutions AG","startDate":"2017-02-22","conditions":"Influenza in Human","enrollment":20},{"nctId":"NCT01685372","phase":"PHASE2","title":"Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-09","conditions":"Solid Organ Transplant Recipient (Liver, Kidney, Heart), Rheumatologic Disorder, Human Immunodeficiency Virus (HIV)","enrollment":16},{"nctId":"NCT03057483","phase":"","title":"Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2017-04-06","conditions":"Influenza Vaccines","enrollment":533},{"nctId":"NCT01239537","phase":"","title":"Swine Flu (Influenza A H1N1) Follow on Vaccine Study","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2010-11","conditions":"Influenza","enrollment":560},{"nctId":"NCT02655874","phase":"PHASE4","title":"Tropical Influenza Control Strategies for the Elderly","status":"COMPLETED","sponsor":"Tan Tock Seng Hospital","startDate":"2016-05","conditions":"Influenza, Human","enrollment":200},{"nctId":"NCT01264601","phase":"NA","title":"Safe Administration of Flu Vaccine to Egg Allergic Children","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2010-10","conditions":"Egg Allergy","enrollment":31},{"nctId":"NCT02362919","phase":"","title":"Influenza Vaccination Among the Elderly Individuals","status":"COMPLETED","sponsor":"Helmholtz Centre for Infection Research","startDate":"2015-02","conditions":"Influenza","enrollment":200},{"nctId":"NCT03022396","phase":"PHASE4","title":"T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010","status":"COMPLETED","sponsor":"Stanford University","startDate":"2010-09","conditions":"Influenza","enrollment":82},{"nctId":"NCT03022422","phase":"PHASE4","title":"T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-09","conditions":"Influenza","enrollment":63},{"nctId":"NCT01827462","phase":"PHASE4","title":"Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-10","conditions":"Influenza","enrollment":136},{"nctId":"NCT00858611","phase":"PHASE1","title":"VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-03-03","conditions":"Influenza, Human","enrollment":51},{"nctId":"NCT00995982","phase":"PHASE1","title":"VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 Years","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-10-08","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT01831934","phase":"PHASE4","title":"Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2010-09","conditions":"MELAS Syndrome","enrollment":22},{"nctId":"NCT01987349","phase":"PHASE4","title":"T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Influenza","enrollment":72},{"nctId":"NCT03023176","phase":"PHASE4","title":"T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-09","conditions":"Influenza","enrollment":20},{"nctId":"NCT02987374","phase":"PHASE4","title":"Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-05","conditions":"Influenza","enrollment":10},{"nctId":"NCT02560909","phase":"PHASE4","title":"Adjuvanted Influenza Vaccine in Stem Cell Transplant","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2015-10","conditions":"Transplantation, Influenza Vaccines","enrollment":73},{"nctId":"NCT01737710","phase":"NA","title":"Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-10","conditions":"Dermatitis, Atopic","enrollment":368},{"nctId":"NCT00579345","phase":"PHASE3","title":"Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-10","conditions":"Influenza","enrollment":1522},{"nctId":"NCT01246999","phase":"PHASE4","title":"Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2010-10","conditions":"Influenza","enrollment":34},{"nctId":"NCT00408395","phase":"PHASE2","title":"Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2006-11","conditions":"Influenza","enrollment":281},{"nctId":"NCT00522067","phase":"PHASE2","title":"Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2007-06","conditions":"Influenza Disease","enrollment":52},{"nctId":"NCT00735410","phase":"PHASE3","title":"Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2008-06","conditions":"Seasonal Influenza, Vaccine","enrollment":134},{"nctId":"NCT01210898","phase":"PHASE3","title":"Immunogenicity and Safety of V70P5 Revaccination Subjects","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2010-09","conditions":"Influenza","enrollment":197},{"nctId":"NCT02819180","phase":"","title":"Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2014-04","conditions":"Influenza","enrollment":120},{"nctId":"NCT02819115","phase":"","title":"Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine","status":"COMPLETED","sponsor":"Butantan Institute","startDate":"2013-06","conditions":"Influenza","enrollment":63},{"nctId":"NCT01498718","phase":"PHASE1","title":"Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-12","conditions":"Influenza","enrollment":131},{"nctId":"NCT02101749","phase":"PHASE4","title":"Immune Response of Intradermal and Intramuscular Preparations of Inactive Seasonal Influenza Vaccine in Older Age Group.","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2013-11","conditions":"Influenza, Human","enrollment":221},{"nctId":"NCT02293317","phase":"PHASE2","title":"Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV","status":"COMPLETED","sponsor":"BiondVax Pharmaceuticals ltd.","startDate":"2014-11","conditions":"Influenza","enrollment":37},{"nctId":"NCT02188810","phase":"PHASE1","title":"Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults","status":"UNKNOWN","sponsor":"Folia Biotech Inc.","startDate":"2014-04","conditions":"Flu","enrollment":48},{"nctId":"NCT01152814","phase":"PHASE2","title":"Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2010-06","conditions":"Seasonal Influenza","enrollment":64},{"nctId":"NCT02640989","phase":"PHASE4","title":"Safety and Immunogenicity of Three Seasonal Trivalent Influenza Vaccines in China Military","status":"COMPLETED","sponsor":"Center for Disease Prevention and Control of Beijing Military Region","startDate":"2014-10","conditions":"Influenza","enrollment":292},{"nctId":"NCT01674205","phase":"PHASE1","title":"Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09","conditions":"Influenza, Human","enrollment":36},{"nctId":"NCT01640327","phase":"PHASE3","title":"Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2012-07","conditions":"Human, Influenza","enrollment":126},{"nctId":"NCT00943657","phase":"PHASE3","title":"Yearly Strain Variation Study, 2009/2010","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2009-06","conditions":"Influenza, Seasonal Influenza","enrollment":110},{"nctId":"NCT00976469","phase":"PHASE1, PHASE2","title":"A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2009-09","conditions":"Influenza, Pandemic Influenza","enrollment":400},{"nctId":"NCT01063088","phase":"PHASE3","title":"Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2010-02","conditions":"Influenza","enrollment":211},{"nctId":"NCT02563184","phase":"PHASE4","title":"Seasonal Influenza Vaccine, Quadrivalent Versus Trivalent in Patients With Advanced Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Banner Health","startDate":"2015-09","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":100},{"nctId":"NCT02269852","phase":"PHASE4","title":"The Immunogenicity and Safety of 2013-2014 Seasonal Trivalent Influenza Vaccine","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2013-12","conditions":"Influenza","enrollment":182},{"nctId":"NCT01797029","phase":"PHASE3","title":"A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh","status":"COMPLETED","sponsor":"PATH","startDate":"2013-02","conditions":"Influenza","enrollment":1761},{"nctId":"NCT01625689","phase":"PHASE2","title":"Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine","status":"COMPLETED","sponsor":"PATH Vaccine Solutions","startDate":"2012-06","conditions":"Influenza","enrollment":309},{"nctId":"NCT01587131","phase":"PHASE1","title":"DNA-based Influenza Vaccine in the Elderly","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2012-06","conditions":"Influenza, Human, Orthomyxoviridae Infections, RNA Virus Infections","enrollment":50},{"nctId":"NCT01368796","phase":"PHASE4","title":"Comparison of 4 Influenza Vaccines in Seniors","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2011-07","conditions":"Influenza Vaccine","enrollment":953},{"nctId":"NCT01140009","phase":"PHASE2","title":"Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2010-08","conditions":"Influenza","enrollment":324},{"nctId":"NCT01527825","phase":"PHASE3","title":"Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2012-09","conditions":"Influenza","enrollment":800},{"nctId":"NCT01173211","phase":"PHASE2","title":"2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-09","conditions":"Influenza","enrollment":183},{"nctId":"NCT00784784","phase":"PHASE3","title":"Zanamivir Versus Trivalent Split Virus Influenza Vaccine","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2008-11","conditions":"Influenza","enrollment":64},{"nctId":"NCT01206114","phase":"","title":"Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11","status":"COMPLETED","sponsor":"Finnish Institute for Health and Welfare","startDate":"2010-09","conditions":"Influenza Caused by the 2009 H1N1 Influenza Virus","enrollment":2351},{"nctId":"NCT01916759","phase":"NA","title":"Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-06","conditions":"HIV, Acquired Immunodeficiency Syndrome, Influenza","enrollment":63},{"nctId":"NCT01651104","phase":"PHASE2","title":"Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2012-07","conditions":"Human Influenza","enrollment":63},{"nctId":"NCT02105519","phase":"PHASE4","title":"The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2013-10","conditions":"Immunogenicity and Adverse Drug Effect of Vaccines Influenza, Chronic Kidney Disease","enrollment":200},{"nctId":"NCT01885117","phase":"PHASE3","title":"Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2013-08","conditions":"Human Influenza","enrollment":125},{"nctId":"NCT01209780","phase":"PHASE3","title":"Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2010-09","conditions":"Seasonal Influenza","enrollment":3116},{"nctId":"NCT01819155","phase":"PHASE2","title":"Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa","status":"COMPLETED","sponsor":"PATH","startDate":"2013-04","conditions":"Influenza","enrollment":296}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Seasonal trivalent vaccine","genericName":"Seasonal trivalent vaccine","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"The seasonal trivalent influenza vaccine stimulates the immune system to produce antibodies against three strains of influenza virus, providing protection against seasonal flu infection. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}